Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-09-02 | Amended | $500,000 | Unknown | Other | SEC link | |
2025-09-02 | Amended | $500,000 | Unknown | Other | SEC link | |
2024-09-03 | Amended | $480,000 | $330,000 | Other | 06b | SEC link |
2023-11-06 | New | $150,000 | $150,000 | Other | 06b | SEC link |
Name | Role |
---|---|
Michael Andre Liss | Director, Executive |